A large body of evidence indicates that high intakes of fruit and vegetables are associated with a reduced risk of cancer at several sites. The association is generally most marked for epithelial cancers, apparently stronger for those of the digestive and respiratory tracts, and somewhat weaker for hormone-related cancers. The relationship between frequency of consumption of vegetables and fruit and cancer risk was analysed using data from a series of case-control studies conducted in northern Italy since 1983. The relative risks (RRs) for most common neoplasms ranged from 0.2 to 0.5 for the highest compared with the lowest tertile of vegetable intake. Protective effects were highest for epithelial neoplasms, but were also observed for hormone-related neoplasms. Fruit was related to reduced RRs for cancers of the oral cavity and pharynx, oesophagus, stomach, larynx, as well as of the urinary tract. There was a specific and consistent pattern of protection by tomatoes, a typical Mediterranean food, with RRs between 0.4 and 0.7, most notably for gastrointestinal neoplasms. No significant association was observed between fruit and vegetable consumption and non-epithelial lymphoid neoplasms. For digestive tract cancer, population attributable risks for low intake of fresh vegetables and fruit ranged from 15 to 40% of all cases in this Mediterranean population. Combined with tobacco and alcohol, the population attributable risks exceeded 85% for men and 55% for women for upper digestive and respiratory tract neoplasms. Thus, from a public health viewpoint, epidemiological evidence indicates that a substantial reduction in epithelial cancer risk can be obtained by increasing fruit and vegetable consumption.
The relationship between hormonal therapy for menopause (hormone replacement therapy, HRT) and the risk of epithelial ovarian cancer was evaluated in a collaborative re-analysis of 4 European case-control studies, 2 conducted in Greece and 1 each in Italy and the United Kingdom, including a total of 1,470 ovarian cancer cases and 3,271 hospital controls. Odds ratios (ORs) for HRT use were derived after allowance for study centre, age, socio-economic level, parity, menopausal status, type of menopause, age at menopause and oral contraceptive use. Overall, 109 (8.0%) ovarian cancer cases and 146 (4.7%) controls had ever used HRT, corresponding to an adjusted OR of 1.71 (95% confidence interval 1.30–2.25). The point estimates of the OR were 1.77 in the first Greek study, 1.40 in the second Greek study, 1.66 in the Italian study and 1.68 in the British study. Adjustment for possible confounders, including menopausal status, type of menopause, age at menopause and oral contraceptive use, slightly increased the OR. Limiting the analysis to women with information on relevant aspects of HRT use revealed a weak positive association with duration and some evidence that the excess relative risk for ovarian cancer declined with time since last use. These findings are compatible with a promoting effect of HRT in ovarian carcinogenesis. It is also possible, however, that the positive association reflects chance or selective administration of HRT to high-risk individuals, since until recently in Europe HRT was prescribed mainly for alleviation of peri-menopausal symptoms. Int. J. Cancer 80:848–851, 1999. © 1999 Wiley-Liss, Inc.
Alcohol consumption has been linked to an increased risk for various types of cancer. A combined analysis of more than 200 studies assessing the link between alcohol and various types of cancer (i.e., a meta-analysis) sought to investigate this association in more detail. This meta analysis found that alcohol most strongly increased the risks for cancers of the oral cavity, pharynx, esophagus, and larynx. Statistically significant increases in risk also existed for cancers of the stomach, colon, rectum, liver, female breast, and ovaries. Several mechanisms have been postulated through which alcohol may contribute to an increased risk of cancer. Concurrent tobacco use, which is common among drinkers, enhances alcohol’s effects on the risk for cancers of the upper digestive and respiratory tract. The analysis did not identify a threshold level of
The relation between body mass (BMI) and soft-tissue sarcoma (STS) risk was evaluated in a case-control study from Northern Italy based on 217 incident STS and 1297 hospital controls. The risk of STS rose with BMI, with multivariate odds ratios of 3.49 (95% confidence interval (CI) 1.06-11.55) among men and 3.26 (95% CI 1.27-8.35) among women with a BMI > 30 kg m(-2) compared to those with BMI < or = 20 kg m(-2).
Read moreFERNANDEZ, Esteve; VECCHIA, CARLO LA; PORTA, Miquel; NEGRI, Eva; D'AVANZO, BARBARA; BOYLE, PETER Author Information
Read moreWe studied the determinants of low bone mineral density, using data from a population-based screening program of osteoporosis carried out among 1,373 women (age 40-64 years) in the province of Pordenone, Italy, by means of dual photon absorptiometry of the lumbar spine. Menopause had a major effect on bone mineral density. Age had little influence before menopause. In multivariate linear regression analyses, weight was the strongest predictor of bone mineral density in pre- as well as postmenopausal women. After the inclusion in a single model of a term for current weight, weight at ages 12 and 30 years explained some additional variance, whereas high waist-to-hip ratio (an indicator of central adiposity) had no influence. Smoking 15 or more cigarettes per day entailed a small increased risk of osteoporosis, but this effect, independent of weight, appeared to be restricted to premenopausal women. No food or micronutrient that we examined was predictive of bone mineral density, nor was coffee or alcoholic beverage intake.
Read moreThe report of an increase of ovarian cancer risk among women who had used fertility drugs prompted us to analyse the relationship between fertility drugs and ovarian cancer in a case-control study which has been ongoing in four areas of Italy since 1992. The present analysis is based on 195 epithelial ovarian cancer cases and 1339 controls admitted to hospital for diseases other than gynaecological or malignant conditions. Fewer ovarian cancer cases than controls reported use of fertility drugs (odds ratio, after allowance for potential confounding factors: 0.7, 95% confidence interval: 0.2-3.3). Among nulligravid women, 5/177 control women compared with 0/36 cancer cases reported having ever used fertility drugs. Although only based on small numbers of women who were suffering from ovarian cancer and who had also used fertility drugs, the present study indicated that a role of ovarian stimulation in the aetiology of epithelial ovarian cancer is not established, although it is worth investigating.
Read moreThe relationship between coffee, decaffeinated coffee and tea intake and risk of cancers of the colon and rectum was considered combining data from 2 case-control studies, one conducted between 1985 and 1991 in Northern Italy and the other between 1991 and 1996 in 6 Italian centers. Cases were patients below age 80, with histologically confirmed cancer of the colon (n = 2,166) or rectum (n = 1,364), and controls were 7,057 patients admitted to hospital for a wide spectrum of acute, non-neoplastic, non-digestive tract diseases. Compared with coffee non-drinkers, the risk of colon cancer was reduced in drinkers of 4 or more cups/day [multivariate odds ratios (ORs) 0.73; 95% confidence intervals 0.60-0.89), with a significant trend in risk with dose; no significant association emerged between coffee drinking and risk of rectal cancer (OR 1.00 for drinkers of 4 or more cups/day). Decaffeinated coffee was consumed in small amounts by about 4% of cases and controls and the OR was 0.92 for colon and 0.88 for rectal cancers. Tea consumption was generally limited to 1 cup/day or to occasional intake and did not substantially modify the risk of colon and rectal cancers. No significant heterogeneity was found for the inverse relationship between coffee intake and colon cancer risk across strata of age at diagnosis, sex, smoking status, total alcohol and meat and vegetable intake, while the protection of coffee was stronger in people eating 3 or more meals/day. Thus, our results confirm that coffee intake has a quantifiable protective effect on colon cancer risk.
Read moreIn order to assess the comparability and reproducibility of information from a questionnaire used in a case-control study on digestive tract cancers conducted in Italy, a total of 400 subjects were randomly selected from a large sample of hospital controls and contacted at home to repeat the interview. Of these, 294 (73%) subjects were re-interviewed. Mean values of intake were computed for the 400 subjects selected, and among the 294 responders for the first and second interview. These values were comparable, most of them being within a 10% range. Spectrum correlation coefficient (rs) values of consumption between the first and second interview were > 0.65 for consumption of pastries, pasta or rice, bread, fish, milk, green vegetables, eggs and apples; between 0.50 and 0.65 for meat, chicken, liver, ham, cold cuts, cheese, fruit, cabbage, carrots, tomatoes, peppers, salad, citrus fruit and melon; and lower than 0.50 for a few infrequently eaten foods. For all foods, the estimated average weekly intake in the second interview increased consistently and substantially with increasing tertile of the first interview. This study shows a satisfactory comparability of dietary information from subjects interviewed at home with that provided during their original interview in the hospital, and a good reproducibility of information collected in the two settings.
Read moreA substantial amount of epidemiological evidence indicates that vegetables and fruit are associated with reduced risk of several cancer sites (Willett and Trichopoulos, 1996; World Cancer Research Fund, 1997), although the issue is open to discussion (Botterweck et al., 1998). The relation between frequency of consumption of vegetables and fruit and cancer risk was analyzed using data from a series of case-control studies conducted in northern Italy between 1983 and 1990 (Negri et al., 1991). For digestive tract neoplasms, the relative risks ranged between 0.2 and 0.5 for the highest compared with the lowest tertile of vegetable intake. Protective effects were also observed for hormone-related epithelial neoplasms. Fruit was related to reduced relative risks for cancers of the upper digestive tract, stomach and urinary tract (Negri et al., 1991). For digestive tract cancers, population attributable risks for low intake (i.e., <2 vs. ≥4 portions per day) of vegetables and fruit ranged between 15 and 40% (Tavani and La Vecchia, 1995). Given the widespread interest in the issue (Nelson, 1996; Potter and Steinmetz, 1996), we have updated our findings, including data collected up to 1997. Thus, the relation between frequency of consumption of green vegetables and fruit and cancer risk has been analyzed using data from an integrated series of case-control studies conducted in greater Milan and the province of Pordenone, northern Italy, between 1983 and 1997. For breast and colorectal cancers, only data collected until 1991 were included. The overall dataset included the following incident, histologically confirmed cancers, below age 75 years: oral cavity and pharynx, 524; esophagus, 410; stomach, 745; colon, 955; rectum, 625; liver, 435; gallbladder, 65; pancreas, 402; larynx, 388; breast, 3,412; endometrium, 750; ovary, 971; soft tissue sarcomas, 217; prostate, 127; bladder, 431; kidney, 190; thyroid, 428; Hodgkin's disease, 201; non-Hodgkin's lymphomas, 529; myelomas, 185; and a total of 10,058 controls admitted to hospital for acute, non-neoplastic conditions, unrelated to long-term dietary modifications (30% traumas, 16% non-traumatic orthopaedic conditions, 29% acute surgical diseases, 25% other miscellaneous). All interviews were conducted in hospital, and, on the average, refusal rate of eligible subjects (cases and controls) was below 5%. All questionnaires comprised a basic structured section, including sociodemographic factors and general characteristics and habits. Patients were asked to indicate the frequency of consumption per week of selected indicator foods, including between 14 and 37 items (D'Avanzo et al., 1997). The questionnaires also included a summary question on total vegetable and fruit consumption, thus making possible a combination of data from various studies. Multivariate odds ratios (OR) and corresponding 95% confidence intervals (CI) for subsequent tertiles of vegetable and fruit consumption were derived after allowance for age (quinquennia), sex, calendar year at interview, area of residence (Milan/Pordenone/other northern regions/other regions), education (<7, 7–11, ≥12 years), smoking (never, ex, current ≤15, ≥15 cigarettes per day) and alcohol consumption (0, <2, 2–4, >4 drinks per day) (Breslow and Day, 1980). Further allowance for body mass index did not appreciably modify any of the ORs. The best approximate tertile cutoffs were 7 and 10 portions per week for vegetables and 7 and 14 portions for fruit. For vegetables (Table I), a consistent pattern of protection was observed for all epithelial cancers, with ORs in the highest tertile of intake between 0.3 and 0.7 for digestive sites, 0.4 for larynx, between 0.5 and 0.8 for breast and female genital tract, around 0.2 for cancers of the prostate and urinary tract and 0.8 for the thyroid. In contrast, no appreciable association was observed for non-epithelial neoplasms, the ORs ranging between 0.7 and 1.1 for the highest tertile of consumption for lymphomas and myeloma. None of these estimates for non-epithelial neoplasms was significant. Likewise, for soft tissue sarcomas, which were not included in the previous report (Negri et al., 1991), the ORs were 1.1 for the intermediate and 1.3 for the highest vegetable consumption tertile. With reference to fruit (Table II), strong protection was observed for cancers of the upper digestive tract (oral cavity and pharynx, OR = 0.5 for the highest tertile), esophagus (OR = 0.4), stomach (OR = 0.4), as well as for colon (OR = 0.6), rectum (OR = 0.8), gallbladder (OR = 0.4), pancreas (OR = 0.7) and larynx (OR = 0.5). Significant inverse trends in risk were also observed for cancers of the prostate (OR = 0.5), bladder (OR = 0.5) and kidney (OR = 0.6). The associations were inconsistent and showed no appreciable protection for other epithelial neoplasms, including breast, female genital tract and thyroid, as well as for lymphomas and myeloma. For soft tissue sarcomas, the ORs were 1.1 and 1.0 for the intermediate and high fruit consumption tertiles. When subjects in the highest tertile of both vegetable and fruit consumption were compared with those in the lowest tertile of both variables, the ORs were 0.2 (95% CI = 0.1–0.3) for esophagus, 0.3 (95% CI = 0.2–0.4) for stomach, 0.5 (95% CI = 0.3–0.6) for colon, 0.3 (95% CI = 0.2–0.4) for larynx, 0.1 (95% CI = 0.0–0.3) for prostate, 0.1 (95% CI = 0.1–0.2) for bladder and 0.2 (95% CI = 0.1–0.4) for kidney cancer. For other neoplasms, no appreciable joint effect of fruit and vegetable consumption was observed. Our findings confirm, on the basis of a substantially larger dataset, the observation that in this population frequent green vegetable intake is associated with a markedly reduced risk of several common neoplasms and that fruit intake has a favorable effect, too, especially on cancers of the digestive and urinary tracts (Negri et al., 1991). The consistency of the findings in subsequent time periods (1983–1990 and 1991–1997) provides further support for the existence of a real association. However, it has been suggested (Botterweck et al., 1998) that the inverse association of vegetable and fruit consumption is less clear in cohort than in case-control studies, at least for gastric cancer. Even in the absence of a univocal and clear biological explanation (Potter and Steinmetz, 1996), these findings nonetheless may have an immediate and substantial impact on a preventive and public health level (La Vecchia and Tavani, 1998). This work was conducted with the contribution of the Italian Association for Cancer Research. M.S. is a recipient of a fellowship awarded by the Zambon Group, Spain. Carlo La Vecchia* , Liliane Chatenoud*, Silvia Franceschi , Maria Soler*, Fabio Parazzini* ?, Eva Negri*
Read more